AC Immune ACIU
NASDAQ ACIU
$2.47 -0.02 (-0.80%)
At close: Oct 21, 2026 · 4:00 PM EDT

AC Immune (ACIU) Current Debt (2020)

Updated

AC Immune's Current Debt was -$54,204 in the year ended Dec 31, 2018, compared with $207,255 a year earlier.

Analysis

AC Immune (ACIU) Current Debt (2020) Analysis & Trends

  • Per Business Quant data, Current Debt in earlier years was $207,255 in the year ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 AC Immune 249.36 Mn -189.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -859,482.91
Mar 31, 2020 271,901.65
API Access

AC Immune Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ACIU&period=max&api_key=YOUR_API_KEY